Commonwealth Equity Services’s Neuphoria Therapeutics NEUP Stock Holding History

Commonwealth Equity Services’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49K	Hold	11,222	–	–	﹤0.01%	4311
2026 Q1	$45.7K	Buy	11,222 +15	+0.1%	+$63	﹤0.01%	4208
2025 Q4	$43.5K	Buy	+11,207	New	+$79.6K	﹤0.01%	4196

Other funds holding NEUP

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Commonwealth Equity Services's NEUP Position: Q2 2026 in Review

Commonwealth Equity Services held its Neuphoria Therapeutics (NEUP) position steady in Q2 2026 at 11,222 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #4311.

Commonwealth Equity Services first reported a position in NEUP in Q4 2025 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold NEUP as of Q2 2026.

Commonwealth Equity Services held 11,222 shares of Neuphoria Therapeutics worth $49K as of Q2 2026.
Commonwealth Equity Services left its Neuphoria Therapeutics share count unchanged in Q2 2026.
Neuphoria Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4311 holding.
Commonwealth Equity Services first reported a position in Neuphoria Therapeutics in Q4 2025 and has held it in 3 quarters since.
2 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.